Suchergebnisse - "Mundl, Hardi"

PubPharm (48)

1

Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials

enthalten in: Journal of the American College of Cardiology | 2024

von Eikelboom, J. | Mundl, H. | Alexander, J. | +15

2

Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes

enthalten in: Stroke | 2024

von Smith, E. | Shoamanesh, A. | Xu, L. | +116

3

Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation

enthalten in: TH open : companion journal to thrombosis and haemostasis | 2024

von Bhagirath, V. | Kovalova, T. | Wang, J. | +10

4

Cerebral microbleeds and asundexian in non-cardioembolic ischemic stroke : Secondary analyses of the PACIFIC-STROKE randomized trial

enthalten in: International journal of stroke : official journal of the International Stroke Society | 2023

von Balali, P. | Hart, R. | Smith, E. | +10

5

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

enthalten in: Circulation | 2022

von Rao, S. | Kirsch, B. | Bhatt, D. | +114

CommentIn: Circulation. 2022 Oct 18;146(16):1207-1209. - PMID 36030388

6

SUBSTITUTED OXOPYRIDINE DERIVATIVES FOR THE TREATMENT AND/OR PROPHYLAXIS OF THROMBOTIC OR THROMBOEMBOLIC DISORDERS AND/OR THROMBOTIC OR THROMBOEMBOLIC COMPLICATIONS

enthalten in: Europäisches Patentamt | 2022

von HEITMEIER STEFAN | MUNDL HARDI

7

Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke) : an international, randomised, double-blind, placebo-controlled, phase 2b trial

enthalten in: Lancet (London, England) | 2022

von Shoamanesh, A. | Mundl, H. | Smith, E. | +32

8

Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source : NAVIGATE ESUS MRI substudy

enthalten in: International journal of stroke : official journal of the International Stroke Society | 2022

von Sharma, M. | Smith, E. | Pearce, L. | +22

9

Pandemic-proof recruitment and engagement in a fully decentralized trial in atrial fibrillation patients (DeTAP)

enthalten in: NPJ digital medicine | 2022

von Sarraju, A. | Seninger, C. | Parameswaran, V. | +14

10

Rivaroxaban versus aspirin on functional and cognitive outcomes after embolic stroke of undetermined source : NAVIGATE ESUS trial

enthalten in: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association | 2022

von Bosch, J. | Pearce, L. | Sharma, M. | +7

1
2
3
4
5
Nächster »
[5]